2009 annual financial data

Celldex Therapeutics 2009 Net margin

Celldex Therapeutics 2009 net margin with verified reported values.

Direct answer

Net margin was -240.61%.

Operating income was -32,854,000 USD and net income was -36,525,000 USD.
Operating cash flow was -29,869,000 USD.

Get free Celldex Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
15,180,000 USD
Operating income
-32,854,000 USD
Net income
-36,525,000 USD
Operating cash flow
-29,869,000 USD